UniProt ID | RPGP2_HUMAN | |
---|---|---|
UniProt AC | Q684P5 | |
Protein Name | Rap1 GTPase-activating protein 2 | |
Gene Name | RAP1GAP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 730 | |
Subcellular Localization | Cytoplasm . Cytoplasm, perinuclear region . | |
Protein Description | GTPase activator for the nuclear Ras-related regulatory protein RAP-1A (KREV-1), converting it to the putatively inactive GDP-bound state.. | |
Protein Sequence | MFGRKRSVSFGGFGWIDKTMLASLKVKKQELANSSDATLPDRPLSPPLTAPPTMKSSEFFEMLEKMQGIKLEEQKPGPQKNKDDYIPYPSIDEVVEKGGPYPQVILPQFGGYWIEDPENVGTPTSLGSSICEEEEEDNLSPNTFGYKLECKGEARAYRRHFLGKDHLNFYCTGSSLGNLILSVKCEEAEGIEYLRVILRSKLKTVHERIPLAGLSKLPSVPQIAKAFCDDAVGLRFNPVLYPKASQMIVSYDEHEVNNTFKFGVIYQKARQTLEEELFGNNEESPAFKEFLDLLGDTITLQDFKGFRGGLDVTHGQTGVESVYTTFRDREIMFHVSTKLPFTDGDAQQLQRKRHIGNDIVAIIFQEENTPFVPDMIASNFLHAYIVVQVETPGTETPSYKVSVTAREDVPTFGPPLPSPPVFQKGPEFREFLLTKLTNAENACCKSDKFAKLEDRTRAALLDNLHDELHAHTQAMLGLGPEEDKFENGGHGGFLESFKRAIRVRSHSMETMVGGQKKSHSGGIPGSLSGGISHNSMEVTKTTFSPPVVAATVKNQSRSPIKRRSGLFPRLHTGSEGQGDSRARCDSTSSTPKTPDGGHSSQEIKSETSSNPSSPEICPNKEKPFMKLKENGRAISRSSSSTSSVSSTAGEGEAMEEGDSGGSQPSTTSPFKQEVFVYSPSPSSESPSLGAAATPIIMSRSPTDAKSRNSPRSNLKFRFDKLSHASSGAGH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MFGRKRSVSFGGFG -CCCCCCCCCCCCCC | 25.75 | 22617229 | |
9 | Phosphorylation | FGRKRSVSFGGFGWI CCCCCCCCCCCCCCC | 21.30 | 23401153 | |
23 | Phosphorylation | IDKTMLASLKVKKQE CCHHHHHHCCCCHHH | 25.43 | 28060719 | |
34 | Phosphorylation | KKQELANSSDATLPD CHHHHCCCCCCCCCC | 24.80 | 28450419 | |
35 | Phosphorylation | KQELANSSDATLPDR HHHHCCCCCCCCCCC | 30.95 | 28450419 | |
38 | Phosphorylation | LANSSDATLPDRPLS HCCCCCCCCCCCCCC | 43.76 | 26657352 | |
45 | Phosphorylation | TLPDRPLSPPLTAPP CCCCCCCCCCCCCCC | 27.44 | 23401153 | |
49 | Phosphorylation | RPLSPPLTAPPTMKS CCCCCCCCCCCCCCH | 42.78 | 22115753 | |
53 | Phosphorylation | PPLTAPPTMKSSEFF CCCCCCCCCCHHHHH | 35.85 | 28450419 | |
56 | Phosphorylation | TAPPTMKSSEFFEML CCCCCCCHHHHHHHH | 25.03 | 26074081 | |
57 | Phosphorylation | APPTMKSSEFFEMLE CCCCCCHHHHHHHHH | 32.67 | 26074081 | |
70 (in isoform 2) | Phosphorylation | - | 57.58 | - | |
85 | Phosphorylation | PQKNKDDYIPYPSID CCCCCCCCCCCCCHH | 17.58 | 27642862 | |
182 | Phosphorylation | SLGNLILSVKCEEAE CCCCEEEEEECCCCC | 16.73 | 24719451 | |
201 (in isoform 2) | Ubiquitination | - | 47.79 | - | |
216 | Ubiquitination | IPLAGLSKLPSVPQI CCCCCHHCCCCHHHH | 70.25 | - | |
241 | Phosphorylation | LRFNPVLYPKASQMI CCCCCCCCCCHHHEE | 11.70 | 26074081 | |
268 | Ubiquitination | KFGVIYQKARQTLEE EEEHHHHHHHHHHHH | 28.68 | - | |
304 | Ubiquitination | TITLQDFKGFRGGLD EEEHHHCCCCCCCCC | 66.48 | - | |
405 (in isoform 3) | Ubiquitination | - | 15.65 | 21906983 | |
409 (in isoform 2) | Ubiquitination | - | 4.05 | 21906983 | |
418 | Phosphorylation | TFGPPLPSPPVFQKG CCCCCCCCCCHHHCC | 49.90 | 27050516 | |
424 (in isoform 1) | Ubiquitination | - | 66.04 | 21906983 | |
424 | Ubiquitination | PSPPVFQKGPEFREF CCCCHHHCCHHHHHH | 66.04 | 2190698 | |
435 | Ubiquitination | FREFLLTKLTNAENA HHHHHHHHHHCHHHH | 53.97 | - | |
451 | Ubiquitination | CKSDKFAKLEDRTRA CCCCHHHCHHHHHHH | 56.39 | - | |
496 | Phosphorylation | GHGGFLESFKRAIRV CCCCHHHHHHHHHHH | 37.91 | - | |
505 | Phosphorylation | KRAIRVRSHSMETMV HHHHHHHCCCCCEEE | 19.63 | 23401153 | |
507 | Phosphorylation | AIRVRSHSMETMVGG HHHHHCCCCCEEECC | 21.40 | 23401153 | |
510 | Phosphorylation | VRSHSMETMVGGQKK HHCCCCCEEECCEEC | 14.44 | 28450419 | |
518 | Phosphorylation | MVGGQKKSHSGGIPG EECCEECCCCCCCCC | 29.89 | 28555341 | |
520 | Phosphorylation | GGQKKSHSGGIPGSL CCEECCCCCCCCCCC | 45.89 | 26552605 | |
526 | Phosphorylation | HSGGIPGSLSGGISH CCCCCCCCCCCCCCC | 17.63 | 26552605 | |
528 | Phosphorylation | GGIPGSLSGGISHNS CCCCCCCCCCCCCCC | 36.35 | 26552605 | |
532 | Phosphorylation | GSLSGGISHNSMEVT CCCCCCCCCCCEEEE | 21.64 | 26552605 | |
535 | Phosphorylation | SGGISHNSMEVTKTT CCCCCCCCEEEEECC | 15.76 | 26552605 | |
539 | Phosphorylation | SHNSMEVTKTTFSPP CCCCEEEEECCCCCC | 14.90 | 26552605 | |
541 | Phosphorylation | NSMEVTKTTFSPPVV CCEEEEECCCCCCEE | 24.57 | 28450419 | |
542 | Phosphorylation | SMEVTKTTFSPPVVA CEEEEECCCCCCEEE | 24.54 | 28450419 | |
544 | Phosphorylation | EVTKTTFSPPVVAAT EEEECCCCCCEEEEE | 26.63 | 25159151 | |
556 | Phosphorylation | AATVKNQSRSPIKRR EEEECCCCCCCCCCC | 44.08 | 29514088 | |
558 | Phosphorylation | TVKNQSRSPIKRRSG EECCCCCCCCCCCCC | 35.90 | 26055452 | |
564 | Phosphorylation | RSPIKRRSGLFPRLH CCCCCCCCCCCCCCC | 43.83 | 22499768 | |
572 | Phosphorylation | GLFPRLHTGSEGQGD CCCCCCCCCCCCCCC | 47.17 | 28102081 | |
574 | Phosphorylation | FPRLHTGSEGQGDSR CCCCCCCCCCCCCCC | 39.44 | 28102081 | |
580 | Phosphorylation | GSEGQGDSRARCDST CCCCCCCCCCCCCCC | 34.36 | 30576142 | |
586 | Phosphorylation | DSRARCDSTSSTPKT CCCCCCCCCCCCCCC | 33.54 | 25884760 | |
587 | Phosphorylation | SRARCDSTSSTPKTP CCCCCCCCCCCCCCC | 17.28 | 30576142 | |
588 | Phosphorylation | RARCDSTSSTPKTPD CCCCCCCCCCCCCCC | 35.85 | 28060719 | |
589 | Phosphorylation | ARCDSTSSTPKTPDG CCCCCCCCCCCCCCC | 49.14 | 30576142 | |
590 | Phosphorylation | RCDSTSSTPKTPDGG CCCCCCCCCCCCCCC | 28.68 | 28060719 | |
593 | Phosphorylation | STSSTPKTPDGGHSS CCCCCCCCCCCCCCC | 28.02 | 23401153 | |
599 | Phosphorylation | KTPDGGHSSQEIKSE CCCCCCCCCHHHCCC | 36.67 | 23403867 | |
600 | Phosphorylation | TPDGGHSSQEIKSET CCCCCCCCHHHCCCC | 26.59 | 23403867 | |
605 | Phosphorylation | HSSQEIKSETSSNPS CCCHHHCCCCCCCCC | 52.33 | 22617229 | |
607 | Phosphorylation | SQEIKSETSSNPSSP CHHHCCCCCCCCCCC | 44.54 | 22115753 | |
608 | Phosphorylation | QEIKSETSSNPSSPE HHHCCCCCCCCCCCC | 24.86 | 23401153 | |
609 | Phosphorylation | EIKSETSSNPSSPEI HHCCCCCCCCCCCCC | 61.24 | 23401153 | |
612 | Phosphorylation | SETSSNPSSPEICPN CCCCCCCCCCCCCCC | 63.88 | 25159151 | |
613 | Phosphorylation | ETSSNPSSPEICPNK CCCCCCCCCCCCCCC | 28.01 | 23401153 | |
620 | Acetylation | SPEICPNKEKPFMKL CCCCCCCCCCCCEEE | 52.86 | 19826871 | |
637 | Phosphorylation | NGRAISRSSSSTSSV CCEEECCCCCCCCCC | 27.99 | 28270605 | |
638 | Phosphorylation | GRAISRSSSSTSSVS CEEECCCCCCCCCCC | 27.48 | 26657352 | |
639 | Phosphorylation | RAISRSSSSTSSVSS EEECCCCCCCCCCCC | 38.59 | 28270605 | |
640 | Phosphorylation | AISRSSSSTSSVSST EECCCCCCCCCCCCC | 33.97 | 28270605 | |
641 | Phosphorylation | ISRSSSSTSSVSSTA ECCCCCCCCCCCCCC | 27.28 | 28270605 | |
642 | Phosphorylation | SRSSSSTSSVSSTAG CCCCCCCCCCCCCCC | 30.59 | 28270605 | |
643 | Phosphorylation | RSSSSTSSVSSTAGE CCCCCCCCCCCCCCC | 26.55 | 28270605 | |
645 | Phosphorylation | SSSTSSVSSTAGEGE CCCCCCCCCCCCCCC | 24.74 | 28270605 | |
646 | Phosphorylation | SSTSSVSSTAGEGEA CCCCCCCCCCCCCCC | 21.81 | 28270605 | |
647 | Phosphorylation | STSSVSSTAGEGEAM CCCCCCCCCCCCCCC | 31.04 | 28270605 | |
662 | Phosphorylation | EEGDSGGSQPSTTSP CCCCCCCCCCCCCCC | 42.30 | - | |
665 | Phosphorylation | DSGGSQPSTTSPFKQ CCCCCCCCCCCCCCE | 36.36 | 26074081 | |
666 | Phosphorylation | SGGSQPSTTSPFKQE CCCCCCCCCCCCCEE | 37.67 | 26074081 | |
667 | Phosphorylation | GGSQPSTTSPFKQEV CCCCCCCCCCCCEEE | 38.45 | 26074081 | |
668 | Phosphorylation | GSQPSTTSPFKQEVF CCCCCCCCCCCEEEE | 28.55 | 26074081 | |
677 | Phosphorylation | FKQEVFVYSPSPSSE CCEEEEEECCCCCCC | 11.91 | 26074081 | |
678 | Phosphorylation | KQEVFVYSPSPSSES CEEEEEECCCCCCCC | 17.38 | 26074081 | |
680 | Phosphorylation | EVFVYSPSPSSESPS EEEEECCCCCCCCCC | 31.32 | 26074081 | |
682 | Phosphorylation | FVYSPSPSSESPSLG EEECCCCCCCCCCCC | 51.59 | 26074081 | |
683 | Phosphorylation | VYSPSPSSESPSLGA EECCCCCCCCCCCCC | 45.54 | 26074081 | |
685 | Phosphorylation | SPSPSSESPSLGAAA CCCCCCCCCCCCCCC | 23.03 | 26074081 | |
687 | Phosphorylation | SPSSESPSLGAAATP CCCCCCCCCCCCCCC | 49.03 | 28270605 | |
693 | Phosphorylation | PSLGAAATPIIMSRS CCCCCCCCCEEECCC | 15.42 | 28270605 | |
698 | Phosphorylation | AATPIIMSRSPTDAK CCCCEEECCCCCCHH | 21.14 | 28270605 | |
700 | Phosphorylation | TPIIMSRSPTDAKSR CCEEECCCCCCHHHC | 25.50 | 28270605 | |
702 | Phosphorylation | IIMSRSPTDAKSRNS EEECCCCCCHHHCCC | 50.24 | 28270605 | |
706 | Phosphorylation | RSPTDAKSRNSPRSN CCCCCHHHCCCCCCC | 38.11 | 30576142 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
7 | S | Phosphorylation |
| 15632203 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPGP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of RPGP2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; THR-49 AND SER-544,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-609 AND SER-613, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND THR-49, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND MASSSPECTROMETRY. | |
"Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed inhuman platelets."; Schultess J., Danielewski O., Smolenski A.P.; Blood 105:3185-3192(2005). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION,PHOSPHORYLATION AT SER-7, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,AND MUTAGENESIS OF SER-7 AND ASN-357. |